3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

UBC is excited for the direction sales and marketing will take under Anthony.
Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.

BLUE BELL, P.A. 30 April 2024 – United BioSource LLC (UBC), a leading provider of evidence development solutions to the biopharmaceutical industry, today announced the appointment of Anthony Luttenberger as its new Chief Commercial Officer.

Anthony brings extensive executive leadership and strategic sales experience, spanning the pharmaceutical product life cycle including late-stage drug development, clinical trials, and product commercialization, to UBC. He is skilled at leveraging actionable insights derived from real-world data, real-world evidence, outcomes research, robust analytics, and informatics to inform innovative program design.  Anthony will play a crucial role in supporting UBC’s market position through the delivery of a comprehensive commercial strategy.

“We have created positive impact for biopharma by delivering on our commitment of uniting evidence and access” said Bekki Bracken Brown, President & Chief Executive Officer, UBC. “Anthony’s growth mindset, customer engagement skills, and ability to build high-performing teams, strengthen UBC’s ability to consult, design, and deliver solutions that help our customers demonstrate the safety, efficacy, and value of their treatments.”

In his new role, Anthony serves as a member of UBC’s Senior Leadership Team and is responsible for global sales and marketing of UBC’s portfolio of evidence development, safety and risk management, and patient access services.


About UBC

United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to make more informed decisions earlier, meet stakeholder requirements, and, ultimately, drive better patient outcomes. For additional information, visit www.ubc.com.

MEDIA INQUIRIES

Amber Frasketi

Head of Marketing & Strategic Communications

UBC

Phone: +1 215.588.8423

Email: amber.frasketi@ubc.com

Other Recent Posts

Press
3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
Press
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
Press
5 min read

UBC Successfully Implemented REMS Administration Software During HL7® FHIR® Connectathon

UBC demonstrated our commitment to optimizing safe medication use and health outcomes by participating in the HL7® FHIR® Connectathon.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.